Firebrick Pharma Health Care

$0.155 0.005 (3.33%)

High $0.16	Low $0.15	Trades 7	Turnover $4,468	Volume 29,243
30 June 2023 at 3:01pm

Register to track FRE and receive email alerts.

Market Cap (19-Sep) $11,693,158 (0th)	Close (30-Jun) $0.155 0 (0%)	Volume (30-Jun) 29,243	Shortsold (14-Jul) 746 (0.00%) (620th)
52w High $0.088	52w Low $0.038	P/E -	EPS -0.01

	Subject
	FRE FRE Ann: Cleansing Notice
	1 (current) 2 3
	FRE FRE Ann: Application for quotation of securities - FRE
	FRE FRE Ann: June 2022 Quarterly Activity Report & Appendix 4C
	FRE FRE Ann: Firebrick Presents at Euroz Hartleys Healthcare Conference
	FRE FRE Ann: Outcome of s60 appeal for Nasodine and next steps
	FRE FRE Ann: Trading Halt
	FRE FRE Ann: Notification of cessation of securities - FRE
	FRE FRE Ann: Initial Director's Interest Notice - Richard Treagus
	FRE FRE Ann: Proposed issue of securities - FRE
	FRE FRE Ann: Nasodine Patent Granted in Malaysia
	FRE FRE Ann: Firebrick Appoints Dr Richard Treagus as Director
	FRE FRE Ann: Firebrick starts Phase 3 common cold trial of Nasodine
	FRE FRE Ann: March 2022 Quarterly Activity Report & Appendix 4C
	FRE FRE Ann: Firebrick starts COVID-19 trial of Nasodine
	FRE FRE Ann: Investor Presentation - Euroz Hartleys Rottnest Conference
	FRE FRE Ann: Investor Presentation - Euroz Hartleys Rottnest Conference
	FRE FRE Ann: FRE to file appeal seeking immediate approval of Nasodine
	FRE FRE Ann: Nasodine US Patent Granted for COVID-19
	FRE FRE Ann: 31 December Interim Financial Report & Appendix 4D
	FRE FRE Ann: Nasodine in vitro and pilot human COVID-19 studies published
	FRE FRE Ann: Nasodine COVID-19 trial receives SAHPRA approval
	FRE FRE Ann: Becoming a substantial holder - Stephen Goodall
	FRE FRE Ann: Becoming a substantial holder - Peter Molloy
	FRE FRE Ann: Becoming a substantial holder - Firebrick Pharma
	FRE FRE Ann: Initial Director's Interest Notice - Stephen Goodall
	FRE FRE Ann: Initial Director's Interest Notice - Peter Molloy
	FRE FRE Ann: Initial Director's Interest Notice - Phyllis Gardner
	FRE FRE Ann: Pre-Quotation Disclosure
	FRE FRE Ann: Top 20 Holders
	FRE FRE Ann: Distribution Schedule
	FRE FRE Ann: Securities Trading Policy
	FRE FRE Ann: Corporate Governance Statement
	FRE FRE Ann: Employee Incentive Plan
	FRE FRE Ann: Annual Report 30 June 2021
	FRE FRE Ann: Annual Report 30 June 2020
	FRE FRE Ann: Constitution
	FRE FRE Ann: Prospectus
	FRE FRE Ann: Information Form and Checklist
	FRE FRE Ann: Appendix 1A
	FRE FRE Ann: ASX Market Release - Admission and Quotation
	FRE FRE Article: Nasal spray business Firebrick Pharma caps off $7m IPO

Register to track FRE and receive email alerts.

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.07	86,441	0.00 (4.41%)
12-Sep	$0.07	9,012	+0.00 (4.62%)
11-Sep	$0.07	74,462	-0.01 (8.45%)
05-Sep	$0.07	135,388	0.00 (0.00%)
04-Sep	$0.07	157	0.00 (0.00%)
03-Sep	$0.07	13,158	0.00 (5.33%)
29-Aug	$0.08	0	0.00 (0.00%)
28-Aug	$0.08	0	0.00 (0.00%)
22-Aug	$0.08	174,657	0.00 (0.00%)
21-Aug	$0.08	317,245	-0.01 (6.25%)
15-Aug	$0.08	29,901	+0.00 (1.27%)
14-Aug	$0.08	0	0.00 (1.25%)
07-Aug	$0.08	0	+0.00 (3.90%)
31-Jul	$0.08	85,467	0.00 (3.75%)
30-Jul	$0.08	51,750	+0.00 (3.90%)
4 up, 6 down, and 5 flat days